Literature DB >> 19434503

Warfarin in vulnerable older adults with atrial fibrillation.

S Michael Gharacholou1, Richard C Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19434503     DOI： 10.1007/s11239-009-0344-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  25 in total

1.  The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community.

Authors:  D Saliba; M Elliott; L Z Rubenstein; D H Solomon; R T Young; C J Kamberg; C Roth; C H MacLean; P G Shekelle; E M Sloss; N S Wenger
Journal:  J Am Geriatr Soc       Date:  2001-12       Impact factor: 5.562

2.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

3.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

Authors:  Brian F Gage; Yan Yan; Paul E Milligan; Amy D Waterman; Robert Culverhouse; Michael W Rich; Martha J Radford
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

4.  Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall.

Authors:  Brian F Gage; Elena Birman-Deych; Roger Kerzner; Martha J Radford; David S Nilasena; Michael W Rich
Journal:  Am J Med       Date:  2005-06       Impact factor: 4.965

5.  The quality of medical care provided to vulnerable community-dwelling older patients.

Authors:  Neil S Wenger; David H Solomon; Carol P Roth; Catherine H MacLean; Debra Saliba; Caren J Kamberg; Laurence Z Rubenstein; Roy T Young; Elizabeth M Sloss; Rachel Louie; John Adams; John T Chang; Patricia J Venus; John F Schnelle; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2003-11-04       Impact factor: 25.391

Review 6.  New oral anticoagulants in atrial fibrillation.

Authors:  Alexander G G Turpie
Journal:  Eur Heart J       Date:  2007-12-19       Impact factor: 29.983

7.  Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.

Authors:  Daniela Poli; Emilia Antonucci; Rossella Marcucci; Cinzia Fatini; Brunetto Alterini; Lucia Mannini; Michela Falciani; Rosanna Abbate; Gian Franco Gensini; Domenico Prisco
Journal:  Thromb Res       Date:  2007-06-26       Impact factor: 3.944

8.  Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people.

Authors:  Lillian C Min; Marc N Elliott; Neil S Wenger; Debra Saliba
Journal:  J Am Geriatr Soc       Date:  2006-03       Impact factor: 5.562

9.  N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

Authors:  Ziad Hijazi; Lars Wallentin; Agneta Siegbahn; Ulrika Andersson; Christina Christersson; Justin Ezekowitz; Bernard J Gersh; Michael Hanna; Stefan Hohnloser; John Horowitz; Kurt Huber; Elaine M Hylek; Renato D Lopes; John J V McMurray; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2013-04-03       Impact factor: 24.094

10.  Estimation of the warfarin dose with clinical and pharmacogenetic data.

Authors:  T E Klein; R B Altman; N Eriksson; B F Gage; S E Kimmel; M-T M Lee; N A Limdi; D Page; D M Roden; M J Wagner; M D Caldwell; J A Johnson
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.